Last reviewed · How we verify
NCT03814772
To Establish a Blood Transfusion Prediction Model for Liver Transplantation Patients Based on PBM
trial testing Liver transplant in Blood Transfusion Complication in 2,000 participants. Status unknown.
1 December 2019
Quick facts
| Lead sponsor | The Third Xiangya Hospital of Central South University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 20 March 2019 |
| Primary completion | 1 December 2019 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- Liver transplant
Conditions studied
- Blood Transfusion Complication — all drugs for Blood Transfusion Complication →
Sponsor
The Third Xiangya Hospital of Central South University
Who can join
Adults 18 to 65, any sex, with Blood Transfusion Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Based on the principle of patient blood management, this study aims to reduce the risk of blood transfusion in allogeneic liver transplantation patients, to ensure the safety of blood transfusion, and to provide new methods and basis for restrictive blood transfusion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03814772
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Liver transplant
Trials testing the same drug.
- NCT06910722 — Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma After SIRT and Chemotherapy · NA · recruiting
- NCT04993131 — Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma · NA · recruiting
- NCT04742621 — Liver Transplantation for Unresectable Liver Limited Colorectal Metastases · recruiting
Other recruiting trials for Blood Transfusion Complication
Currently open trials in the same condition.
- NCT07309848 — Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs · recruiting
- NCT06443515 — Respiratory Trends During Blood Transfusions in Newborns. · NA · recruiting
- NCT06358079 — Re-infusion of Unwashed Shed Blood During Off-pump Surgery · NA · active not recruiting
- NCT06244264 — The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis · NA · recruiting
- NCT06023056 — Hepatitis B Vaccination After Neonatal Surgery · recruiting
Other The Third Xiangya Hospital of Central South University trials
Trials by the same sponsor.
- NCT07353307 — A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia Afte · Phase 3 · recruiting
- NCT07123207 — Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Dis · NA · recruiting
- NCT07034664 — IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study · recruiting
- NCT07093294 — Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter · recruiting
- NCT07039097 — A Multicenter, Prospective, Randomized, Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resectio · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03814772 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Third Xiangya Hospital of Central South University
- Last refreshed: 21 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03814772.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing